EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.
about
Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System TumorsElevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators.Cancer metabolism as a central driving force of glioma pathogenesismTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling.Systematic characterization of lncRNAs' cell-to-cell expression heterogeneity in glioblastoma cells.Targeting BET bromodomain proteins in solid tumorsHomeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissueSmall genomic insertions form enhancers that misregulate oncogenesGBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity.The challenges associated with molecular targeted therapies for glioblastoma.Advances in the molecular genetics of gliomas - implications for classification and therapy.ChIP-seq in studying epigenetic mechanisms of disease and promoting precision medicine: progresses and future directions.The antiproliferative and apoptotic effects of apigenin on glioblastoma cells.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Bromodomain inhibitors and cancer therapy: From structures to applications.Integrating RNA sequencing into neuro-oncology practice.Biomarkers and therapeutic advances in glioblastoma multiforme.EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity.Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties.Integrated analysis of whole-genome ChIP-Seq and RNA-Seq data of primary head and neck tumor samples associates HPV integration sites with open chromatin marks.Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma.Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.Targeting epidermal growth factor receptor co-dependent signaling pathways in glioblastoma.TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.TRIM59 promotes gliomagenesis by inhibiting TC45 dephosphorylation of STAT3.Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma initiating cells.Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling.Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma.Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts.Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancerLong genes linked to autism spectrum disorders harbor broad enhancer-like chromatin domains
P2860
Q26744268-990C2D38-037F-41EE-867D-D51013D8C15DQ30851277-92810F37-5615-4AE9-BBB4-98DECD021E85Q33847616-513F054B-2F3F-48C6-84DA-ED7729F52F3DQ33884658-4C281CEA-38E1-4309-A41A-576FB4BF0667Q37109769-C5E39A22-30CC-4064-9B86-800E101F414DQ37619860-C4037AA0-64BE-47D3-B397-07ADAA67D8E8Q37626834-D5498A66-98F6-43A2-8CE1-7DA5F4F6146FQ37642694-095B89C5-7781-49DC-A740-198E76691F23Q37694758-BFC24EF5-7AAB-4FDE-9946-1DF7945BC698Q38743460-E96E65A4-89AB-4898-9FFB-FC510515EE10Q38777058-FCFF38A6-D57B-40BA-B015-00D758DF245BQ38851252-EC9CDC33-9576-4214-A8F4-A95FC4BF8852Q38871823-FC17D619-3981-467A-A66A-53AAF2128FBCQ38922319-C4F81C57-1CAC-4594-B9FE-D954F2041677Q39027056-E285E1D6-95FF-4B46-A20F-5257DB13AA5BQ39459649-F004EBDF-59D1-41EF-ACDB-02F3A5D5E258Q40070524-27682721-D990-47A5-9D16-12D4337430E9Q40089704-58EC5836-07E3-43B4-B1B1-3FCADD72DF7AQ40116157-3D59BB51-14DB-4108-B5AB-58C88D19335DQ42278310-BE8A4BDC-D76C-4094-B6A0-28A06A0272B9Q42692999-6395CC6F-3DE7-4BDC-9482-09B5D80A7A10Q43441906-9F3A435A-D24D-42C3-898B-960CE677584DQ45869675-C1BBF024-95DF-46B7-8EB8-B89BFF18676BQ46436702-DDA2D9C8-EA78-4B39-8EDD-5E30DA0776D9Q47279032-5DC775A2-06AC-42BE-99A2-CFCBF5C46F9CQ47828321-3ECFECB3-EF9D-444C-B06E-E3C43D83F451Q47874491-FA1EAE62-9FE8-4D94-90DF-4413218BEA48Q48020980-81F53969-28F8-4577-82FA-EB2406918090Q50100856-D58CF023-E0AD-42E0-A405-A1226AB97C76Q55030833-ECC367FB-3F3D-462D-AF62-942C8EF11B73Q55457087-DB7E06CC-4DC6-4A40-8C0A-05F3678B42EDQ55457106-1D0F8F71-86BC-48DE-A38A-A3E732000B0CQ56937451-40402A59-5659-48EE-949D-791F88D07467Q57635195-4FA2F5B5-92DC-45FE-98AC-C9824D8CC09D
P2860
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
EGFR Mutation Promotes Gliobla ...... ion Factor Network Remodeling.
@ast
EGFR Mutation Promotes Gliobla ...... ion Factor Network Remodeling.
@en
type
label
EGFR Mutation Promotes Gliobla ...... ion Factor Network Remodeling.
@ast
EGFR Mutation Promotes Gliobla ...... ion Factor Network Remodeling.
@en
prefLabel
EGFR Mutation Promotes Gliobla ...... ion Factor Network Remodeling.
@ast
EGFR Mutation Promotes Gliobla ...... ion Factor Network Remodeling.
@en
P2093
P2860
P1433
P1476
EGFR Mutation Promotes Gliobla ...... ion Factor Network Remodeling.
@en
P2093
Ah Young Lee
Andrew K Shiau
Ciro Zanca
David Jenkins
Gary C Hon
Genaro R Villa
P2860
P304
P356
10.1016/J.MOLCEL.2015.09.002
P577
2015-10-06T00:00:00Z